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T lymphocytes develop in the thymus from a 
multistep differentiation program characterized 
by the sequential VDJ rearrangement of the tcrb 
and tcra genes in combination with stringent 
quality control checkpoints. The most imma-
ture T lymphocytes are CD4 and CD8 double-
negative  (DN),  and  this  population  can  be 
further subdivided based upon their expression 
of  CD44  and  CD25  (Godfrey  et  al.,  1993).   
At the CD25+CD44lo DN3 stage, thymocytes 
undergo the -selection checkpoint. DN3 cells 
are  tested  for  the  successful  expression  of  a 
TCR polypeptide in the context of the in-
variant pT subunit and CD3, which together 
form the preTCR (Yamasaki and Saito, 2007). 
DN3  cells  that  have  successfully  rearranged 
TCR undergo proliferative expansion, fur-
ther differentiation, and allelic exclusion of   
the TCR locus. This occurs as DN3 cells lose 
expression of CD25 to become DN4. Subse-
quently, thymocytes express CD8 and CD4, 
which  together  define  the  double-positive 
(DP)  population,  where  tcra  rearrangement   
occurs and the mature TCR is expressed. The 
completion of -selection is contingent upon 
Notch  signaling,  which  is  necessary  for  sur-
vival, metabolic fitness, and proliferation after 
TCR rearrangement (Ciofani and Zuñiga-
Pflucker, 2005; Maillard et al., 2006). Together, 
Notch  and  preTCR  signaling  are  thought   
to constitute the minimal requirements for 
continued differentiation beyond -selection; 
however, our understanding of how the signal-
ing events downstream of these receptors are 
integrated is limited.
The class I phosphatidylinositol 3-kinase   
(PI3K) family of enzymes mediates the phosphory-
lation  of  phosphatidylinositol-4,5-trisphosphate 
(PIP2) to generate phosphatidylinositol-3,4,5-
trisphosphate (PIP3). This lipid binds the pleckstrin   
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T cell development requires phosphatidylinositol 3-kinase (PI3K) signaling with contribu-
tions from both the class IA, p110, and class IB, p110 catalytic subunits. However, the 
receptors on immature T cells by which each of these PI3Ks are activated have not been 
identified, nor has the mechanism behind their functional redundancy in the thymus. Here, 
we show that PI3K signaling from the preTCR requires p110, but not p110. Mice defi-
cient for the class IB regulatory subunit p101 demonstrated the requirement for p101 in  
T cell development, implicating G protein–coupled receptor signaling in -selection. We 
found evidence of a role for CXCR4 using small molecule antagonists in an in vitro model 
of -selection and demonstrated a requirement for CXCR4 during thymic development in 
CXCR4-deficient embryos. Finally, we demonstrate that CXCL12, the ligand for CXCR4, 
allows for Notch-dependent differentiation of DN3 thymocytes in the absence of support-
ing stromal cells. These findings establish a role for CXCR4-mediated PI3K signaling that, 
together with signals from Notch and the preTCR, contributes to continued T cell develop-
ment beyond -selection.
© 2010 Janas et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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thymus, CXCR4 is highly expressed on thymocytes from the 
DN2 to the DP stage (Ara et al., 2003; Plotkin et al., 2003), 
but its role during T cell development is controversial. Both 
CXCR4 and CXCL12 are required for embryo viability, and 
some studies examining T cell lymphopoiesis at fetal stages of 
development have concluded that T cell development is nor-
mal in the absence of CXCR4 (Ma et al., 1998; Zou et al., 
1998) Conversely, competitive chimera studies using donor 
fetal liver cells showed a reduced reconstitution of CXCR4-
deficient thymocytes compared with WT (Ara et al., 2003). 
In addition, cre-mediated CXCR4 deletion in DN1 thymo-
cytes resulted in complete developmental arrest of T cells 
(Plotkin et al., 2003) and human CD34+ cells seeded into 
mouse fetal thymic organ cultures treated with neutralizing 
antibodies to CXCL12 or CXCR4 showed impaired differen-
tiation and reduced numbers of recovered T cells (Hernández-
  López et al., 2002).
We have revealed the role of P110 and P110 in T cell 
development using a combination of genetic and pharma-
cological approaches. Stimulation of different PI3K mutant 
DN4 cells through the preTCR showed that p110 is essen-
tial for the initiation of PI3K signaling from this receptor, but 
we found no role for p110. Experiments with chimeric 
mice and in vitro cell differentiation cultures demonstrated 
the combined deletion of p110 and the class IB regulatory 
subunit p101 recapitulate the phenotype of p110// 
mice, suggesting a requirement for G-protein coupled recep-
tor (GPCR)–dependent PI3K activation during T cell devel-
opment. Further evidence for this was shown using small 
molecule inhibitors of CXCR4 to impede the proliferation 
and differentiation of DN3 thymocytes in vitro. Moreover, 
we found that stimulation of DN3 thymocytes with the che-
mokine CXCL12 elicits a PI3K-mediated signaling response 
which is predominantly p110-dependent, but also involves 
p110.  Analysis  of  CXCR4-deficient  embryos  confirmed 
that signaling through CXCR4 is critical for normal thymic 
T cell development. Using these insights, we tested the re-
quirement for CXCR4 signaling by culturing DN3 cells with 
Notch ligand in the presence or absence of CXCL12. Only 
in the presence of CXCL12 could DN3 cells differentiate to 
become DP. These insights permitted the differentiation and 
expansion of DN3 in the absence of supporting stromal cells 
and that the additional inclusion of a GSK3 inhibitor allowed 
PI3K-mediated accessory cell–free proliferation and differ-
entiation to a similar extent as that seen upon co-culture of 
DN3 thymocytes with stromal cells.
RESULTS
p110, and not p110, is required for preTCR-mediated  
Akt phosphorylation
Although the PI3K pathway has been implicated in preTCR 
signaling, a direct link between the preTCR and individual 
PI3K catalytic subunits has yet to be shown. This is caused in 
part by the technical difficulties of studying signaling events 
initiated by the preTCR, as it is rapidly degraded and difficult 
to detect at the cell surface (Panigada et al., 2002). To determine 
homology domains of effector molecules, which in turn regulate 
cellular processes including survival, proliferation, metabolism, 
differentiation, and movement (Fruman and Bismuth, 2009). 
The class I PI3Ks are comprised of two subgroups designated 
class IA and IB. The class IA subgroup, whose members are   
activated by tyrosine kinase–associated receptors, consists of three 
110-kD catalytic subunits termed , , and  that pair with 
regulatory subunits p50, 55, 85, p85, and p55. The class 
IB subgroup, activated by G protein–coupled receptors, consists 
of p110 that interacts with p101 or p84 regulatory subunits.
Functional redundancy between PI3K isoforms for T cell 
development is revealed in mice lacking both p110 and 
p110 in the germline. These mice have small thymi charac-
terized by a marked reduction in DP thymocyte numbers 
(Webb et al., 2005; Swat et al., 2006; Ji et al., 2007), reflect-
ing defective survival of DP thymocytes (Webb et al., 2005; 
Swat et al., 2006). The conditional deletion in DN T cells of 
phosphatase  and  tensin  homologue,  which  opposes  PI3K   
activity by converting PIP3 to PIP2, rescues T cell develop-
ment  in  mice  with  defective  IL-7  or  preTCR  signaling 
(Hagenbeek et al., 2004; Shiroki et al., 2007). Despite this, it 
remains unclear how P110 and P110 contribute to the ear-
lier stages of T cell development and to which activating re-
ceptors these PI3K isoforms are coupled (Webb et al., 2005; 
Swat  et  al.,  2006).  Genetic  and  biochemical  studies  have   
revealed  important  roles  for  the  PI3K-dependent  protein   
kinases PDK1 and Akt in T cell development (Hinton et al., 
2004; Fayard et al., 2007; Juntilla et al., 2007; Mao et al., 2007). 
DN4 cells of these mutant mice were small and failed to up-
regulate nutrient receptors despite having normal expression 
of intracellular TCR, whereas expression of constitutively 
active Akt resulted in the rescue of the DN3 developmental 
block in Rag2-deficient mice (Mao et al., 2007).
Although the preTCR utilizes protein tyrosine kinases 
for signaling, a direct link between the preTCR and PI3K 
activation has yet to be shown. Similarly, the PI3K effector 
molecules PDK1 and AKT have been reported to be required 
for Notch-dependent metabolic changes in DN3 cells (Ciofani 
and Zuñiga-Pflucker, 2005; Kelly et al., 2007). However, the 
mechanistic  basis  for  the  interaction  between  Notch  and 
PI3K remains to be clarified. Further, the implication of class 
IB PI3K in early T cell development raises the possibility that 
a GPCR may also be involved in this process, but such a   
receptor has not been identified.
Among GPCRs, chemokine receptors are important in 
directing thymocytes through the cortex and medulla during 
their development, thereby guiding thymocytes to the ap-
propriate microenvironment for their specific developmental 
stage (Petrie and Zuñiga-Pflucker, 2007). However, it is not 
known if chemokines can directly contribute to the induc-
tion of thymocyte proliferation and differentiation. CXCL12, 
and its receptor CXCR4, was first identified as a growth fac-
tor for pre B cells (Nagasawa et al., 1994) and using mutant 
mice it was subsequently shown that CXCR4 is critical for   
B cell and myeloid hematopoiesis (Ma et al., 1998; Nagasawa   
et al., 1996; Tachibana et al., 1998; Zou et al., 1998). In the JEM VOL. 207, January 18, 2010 
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shift in median fluorescence indicative of a graded analogue 
response. The increase in phospho-Akt in p110/ DN4 
cells upon anti-CD3 stimulation was similar to the WT, but 
p110/  cells  failed  to  generate  detectable  p-Akt  under 
identical conditions. These results suggested that the p110 
subunit  is  critical  for  PI3K  signaling  from  the  preTCR, 
whereas p110 is dispensable. Moreover, preTCR activation 
of the Erk signaling pathway is independent of either p110 
or p110.
Impaired thymocyte development in mice deficient  
for p110 in combination with p101
p110 is recruited to the G subunits of GPCRs via its   
association with p101 or p84 regulatory subunits (Stephens   
et al., 1997; Suire et al., 2005). We found that p101 mRNA 
was expressed in DN3 and DN4 thymocytes, whereas p84 
whether  p110  and/or  p110  are  required  for  preTCR-
  mediated Akt phosphorylation, we used the OP9-DL1 culture 
system. BM-derived hematopoietic stem cells (HSCs) from 
WT, p110/, or p110/ were cultured in the continued 
presence of IL-7, which enabled differentiation to the DN3/
DN4 stage of T cell development (Huang et al., 2005 and 
unpublished data). Under these culture conditions, we found 
that DN4 cells express detectable CD3 at the cell surface 
(Fig. S1). DN4 cells from WT, p110/, and p110/ cul-
tures were similarly responsive to stimulation with anti-CD3 
antibody  for  the  induction  of  Erk1/2  phosphorylation  as 
measured by flow cytometry (Fig. 1). The staining profile for 
phospho-Erk appeared bi-modal and is thus similar to the 
Erk1/2 response in more mature TCR-stimulated thymo-
cytes (Prasad et al., 2009). In contrast, the staining profile of 
Akt phosphorylation at residue serine 473 showed an overall 
Figure 1.  PI3K p110 is required for preTCR signaling in DN4 thymocytes. (A) Phosphorylated Akt (S473) and (B) phosphorylated Erk1/2 (T202/
Y204) in WT and PI3K mutant DN4 T cells in response to preTCR signaling. Histograms show staining in either resting cells (gray area) or cells stimulated 
with 10 µg/ml of anti-CD3 antibody 2C11 for 5 min (black line). DN4 cells were derived from long-term BM HSC cultures. Intracellular p-Akt and  
p-Erk1/2 were detected using flow cytometry in combination with cell surface markers to distinguish the DN4 population (defined as Thy1.2+ and [CD4/CD8/
CD19/CD25]neg). (C and D) Time course of p-Akt (S473) and pErk induction in WT, p110/, and p110/ cultured DN4 cells in response to stimulation 
with 2C11. Graphs show the mean and SD (n = 3–5) and are comprised of five independent experiments.250 PI3K signals through CXCR4 at -selection | Janas et al.
cells. DN4 cells (CD25–/CD44–) from p110// and 
p101//p110/ mice failed to show increased expression 
of the CD98 heavy chain of amino acid transporters and 
CD71 (transferrin receptor), nor did they show increased for-
ward angle light scatter indicative of cell growth (Fig. 2, B–D). 
This defect was not secondary to a failure to express a pro-
ductively rearranged tcrb gene as the frequency of small DN3 
cells expressing the  polypeptide identified by intracellular 
flow cytometry was not different from the WT (Fig. 2 D). 
Additionally, the amounts of p110 protein were unchanged 
mRNA was undetectable (Fig. S2 A). Thymocytes from mice 
lacking p101 (Suire et al., 2006) had a CD4/CD8 FACS stain-
ing profile similar to the p110/ single mutants (Fig. 2 A),   
and they had a reduced number of DP thymocytes com-
pared with WT (P = 0.01; using the unpaired Student’s t test; 
not depicted). However, mice deficient for both p101 and 
p110 showed thymic atrophy to a similar degree to the 
p110// mice (Fig. 2 A). These mice had a marked in-
crease in the proportion of thymocytes that were CD4–CD8– 
DN and a decrease in the proportion of CD4+CD8+ DP 
Figure 2.  Defective maturation of DN3 thymocytes in mice that lack p110 in combination with either p110 or p101. (A) Flow cytometric  
analysis of CD4 and CD8 expression on T lymphocytes in the thymus from WT and PI3K mutant mice. The percentages of CD4+CD8+ DP and CD4CD8 DN 
cells are shown. The mean thymus cellularity + SEM for each genotype is also shown (n = 9–33). (B) Flow cytometric analysis of the DN3/DN4 thymic subsets 
in PI3K mutant mice (identified as Thy1+ and [CD4/CD8/CD44/B220/CD11b/ NK1.1/Gr1/Ter119/TCR]neg). The percentages of CD25loCD98hi, CD25loCD71hi, 
icTCR, icTCR+FSClo, and icTCR+FSChi are shown. Enumeration of CD25loCD98hi and CD25loCD71hi DN3/DN4 cells (C) and numbers of icTCR+ FSClo and  
FSChi cells (D) for each genotype are shown. In C, graphs represent the mean and SD (n = 3–5). In D, graphs show the mean and SEM (n = 5–27).JEM VOL. 207, January 18, 2010 
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p110/p110 or p101/p110, we created chimeras by re-
constituting recipient mice doubly deficient in Rag2 and the 
common cytokine receptor  chain (Rag2/ Il2rg/) with 
BM from WT, p110//, or p101//p110/ mutant 
mice. Chimeric mice reconstituted with p110// or 
p101//p110/ BM had a reduction in the number of 
DP thymocytes compared with control chimeras reconstituted 
with WT BM (Fig. 3 A). Although the numbers of DN3/
DN4 cells were equivalent to WT chimeras, these cells failed 
to become CD98hi, CD71hi or to increase in size (Fig. 3, B–F). 
In addition, pulse-labeling with the thymidine analogue   
in the absence of p101 (Fig. S2 B). Thus, the phenotype   
observed in the p101//p110/ mice is not a consequence 
of reduced expression of the p110. As p101 is required to 
regulate p110 function we conclude that, in its absence, 
p110 is uncoupled from its activating receptor.
Previous studies have shown that when WT BM is trans-
planted into p110/ recipient mice, thymic development 
is impaired to the same extent as that seen in p110/ mice, 
suggesting a non–cell autonomous role for p110 in T cell 
development (Swat et al., 2006). Therefore, to determine 
whether  there  was  a  thymocyte-intrinsic  requirement  for 
Figure 3.  T lymphocyte development in BM chimeras. (A) CD4 and CD8 expression on thymocytes with the percentages of DP and DN cells shown. 
The average thymus cellularity + SEM for each group is shown (n = 15–20). (B) Expression of CD25 and CD44 on DN thymocytes with the percentages of 
CD44CD25+ and CD44CD25 cells shown. (C) Enumeration of CD44CD25+ and CD44CD25 and CD4+CD8+ DP thymocytes in chimeras reconstituted 
with WT, p110//, and p101//p110/ marrow. Graphs represent the mean and SEM. n = 15–19. (D) Flow cytometric analysis of the DN3/DN4 
thymic subset. The percentages of CD25loCD98hi, CD25loCD71hi, icTCR, icTCR+FSClo, and icTCR+FSChi are shown. Plots and percentages are representa-
tive of at least five individual mice. Enumeration of CD25loCD98hi and CD25loCD71hi cells (E) and icTCR+FSClo and FSChi cells (F) for each genotype are 
shown. (G and H) Analysis of DN3/DN4 cell proliferation by EdU incorporation. Graphs show the mean and SD from analysis of five independent mice.252 PI3K signals through CXCR4 at -selection | Janas et al.
antagonist AMD3100. This small molecule binds to CXCR4 
with  high  specificity  and  inhibits  chemotaxis  of  human 
PBMCs to CXCL12 with an IC50 of 0.16 µM (Hatse et al., 
2002). Culturing DN3 cells in the presence of AMD3100   
inhibited  their  ability  to  become  CD4+CD8+  (Fig.  5).   
The numbers of DP cells recovered after 3 d of culture were 
decreased in a dose-dependent manner, indicating that in 
the absence of CXCR4 signaling DN3 cells had reduced 
proliferation and/or survival. This effect on DN3 cells was 
also seen with a chemically distinct small molecule inhibitor 
of  CXCR4  termed  GSK812397A,  which  inhibits  the 
CXCL12-mediated chemotaxis of the U937 cell line with 
an IC50 of <1 nM (GlaxoSmithKline; personal communica-
tion). These results show that signaling through CXCR4 
contributes to the development of DN3 cells to the DP   
developmental stage.
CXCR4 signals through both PI3K p110 and p110  
in DN3 thymocytes
We sought evidence to determine whether CXCR4 activation 
of PI3K required p110 and/or p110. Using intracellular 
flow cytometry, we measured p-Akt (S473) and p-Erk1/2 
(T202/Y204) levels in freshly isolated thymocytes after in   
vitro stimulation with CXCL12. WT DN3, DN4, and DP, 
5-ethynyl-2-deoxyuridine  (EdU)  revealed  that  both 
p110// and p101//p110/ DN3/4 thymocytes 
incorporated EdU poorly compared with WT (Fig. 3 G-H). 
Defective  expansion  and  differentiation  was  recapitulated   
in vitro using sorted DN3 cells from WT and PI3K single-   
or double mutant mice cultured on OP9-DL1 stromal cells 
(Fig. 4). After 3 d of culture, the majority of WT and PI3K 
single-mutant DN3 cells had proliferated and differentiated 
to become large CD4+CD8+CD98hi cells. However, both 
p110// and p101//p110/ DN3 cells remained 
undifferentiated, did not proliferate, and failed to increase   
in size. Thus, thymocytes have a cell autonomous require-
ment for p110/p110 or p101/p110 to progress be-
yond -selection.
Evidence for the involvement of CXCR4  
at the -selection checkpoint
The in vivo and in vitro requirement for p101 at the -selection 
checkpoint prompted us to seek evidence of a role for a 
GPCR in this process. We observed that CXCL12, the   
ligand for CXCR4, was secreted by the OP9-DL1 stromal 
line (Fig. S3 A). We examined whether CXCL12 was re-
quired for DN3 proliferation and differentiation by culturing 
sorted DN3 cells on OP9-DL1 in the presence of the CXCR4 
Figure 4.  DN3 cells from p110// and p101//p110/ mice fail to differentiate in vitro. 4 × 104 DN3 cells from WT and PI3K mutant 
mice were cultured on OP9-DL1 stroma for 3 d. (A) The percentage of CD4+CD8+ cells. (B) The percentage of CD98+ cells. (C) The number of total 
CD4+CD8+ and CD4CD8 cells recovered. Graphs show each biological sample (black diamond) as well as the mean (black bars) for each group. This  
experiment is representative of three independent replicates.JEM VOL. 207, January 18, 2010 
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of PI3K required for development beyond -selection. To 
address this, we first compared PI3K activity before and after 
-selection by measuring p-Akt (S473) in freshly isolated 
DN3 cells which were either CD98lo or CD98hi (Fig. 7 A) 
We have found that the expression of CD98 in DN3 cells 
correlates with expression of CD27 (data not shown), thus 
identifying DN3 cells with expression of TCR (Taghon   
et al., 2006). Our results show that CD98hi DN3 cells have   
an 1.4-fold increase in detectable p-Akt compared with 
CD98lo cells. This is consistent with increased PI3K activity 
upon -selection.
Although  we  have  demonstrated  that  blocking  the 
CXCR4 signaling pathway inhibited DN3 cell differentia-
tion in vitro, we wanted to determine whether this also af-
fected PI3K activity. To test this, CD98lo DN3 cells were 
cultured on the OP9-DL1 stromal line in the presence of in-
creasing concentrations of AMD3100. Cells were harvested 
at 24-h intervals, and their p-Akt levels were measured. We 
observed an increase in the p-Akt levels of DN3 cells with 
time, which was diminished in the presence of AMD3100 
(Fig. 7, B and C). Thus, signaling through CXCR4 contrib-
utes to PI3K activity. We also measured p-Akt levels in DN3 
but not CD4+ SP, thymocytes showed increased p-Akt and 
p-Erk in response to CXCL12 stimulation (Fig. 6, A and B).   
DN3 cells lacking p110 responded similarly to WT but   
the p-Akt response in CXCL12-stimulated p110/ and 
p101/ DN3 cells was reduced, although not eliminated. 
These results indicate that the PI3K signaling pathway is acti-
vated in DN3 cells in response to CXCL12 and that p110 
and p101 are required for this response. We also measured 
CXCL12-mediated  Akt  in  p110//  DN3  cells  and 
were unable to detect any increase in p-Akt (Fig. 6, A and D). 
Thus, in the absence of p110, p110 also contributes to the 
CXCR4 activation of PI3K. Erk phosphorylation was found 
to be equivalent to WT in all PI3K mutant genotypes show-
ing  that  p110,  p110,  and  p101  were  not  required  for 
CXCL12-mediated Erk phosphorylation and that some as-
pects of CXCR4 signaling are independent of these PI3Ks.
CXCR4 is required for PI3K activation in DN3 thymocytes
Our findings have identified the preTCR and CXCR4 as 
receptors on DN3 cells through which p110 and p110 are 
activated. However, it is unclear whether these receptors   
operate independently or cooperatively to induce activation   
Figure 5.  Inhibition of CXCR4 signaling blocks DN3 cell differentiation. 4 × 104 DN3 cells from WT mice were cultured on OP9-DL1 stromal cells 
for 3 d in the presence of increasing concentrations of AMD3100 or GSK812397A. Cells were harvested, analyzed for the expression of CD4 and CD8 (A),  
and absolute numbers of CD4+CD8+ DP and CD4CD8 DN cells recovered (B). Graphs show the mean and SD. n = 3. This experiment is representative of 
three independent replicates.254 PI3K signals through CXCR4 at -selection | Janas et al.
significant thymic atrophy in CXCR4/ mice (Fig. 8 B), 
which  corresponded  to  reduced  numbers  of  all  thymic   
subsets from DN2 to DP (Fig. 8 C). This phenotype may, 
in part, be attributed to the reduced number of T cell pre-
cursors colonizing the thymus. In addition, we noted a pro-
gressive decrease in the ratio of CXCR4/ to CXCR4+/ 
cells at each successive developmental stage, indicating a 
continual requirement for CXCR4 as thymocytes progress 
through -selection and become DP T cells. Finally, we 
compared the cell size of DN3 and DN4 thymocytes from 
CXCR4+/ and CXCR4/ mice, as we had observed that 
DN4 cells from PI3K mutant mice were smaller compared 
with WT (Fig. 1 D). Unlike the adult thymus, we found 
that there was no increase in size between DN3 and DN4 
thymocytes of the E17.5 embryo. However, both DN3 and 
DN4 cells were significantly smaller in CXCR4/ thymi 
(Fig. 8 D). Collectively, these results suggest CXCR4 is re-
quired during T cell development.
cells isolated ex vivo from PI3K mutant mice (Fig. 7 D).   
Despite  the  requirement  of  p110  for  preTCR-mediated 
Akt  phosphorylation,  p-Akt  levels  in  the  DN3  cells  of 
p110/ mice were similar to WT. In contrast, DN3 cells 
from  p110/,  p101/,  and  p110//  mice  had 
70–80% of WT p-Akt levels, demonstrating a role for the 
class IB subunits in the generation and/or maintenance of 
PI3K activity in DN3 thymocytes.
Impaired thymic development in CXCR4-deficient embryos
To examine the role of CXCR4 in thymocyte develop-
ment,  we  analyzed  thymi  from  CXCR4-deficient  mice. 
CXCR4 is required for embryo viability (Ma et al., 1998; 
Tachibana  et  al.,  1998;  Zou  et  al.,  1998),  therefore  we 
compared T cell development in E17.5 CXCR4+/ and 
CXCR4/ embryos (Fig. 8). We found a decreased pro-
portion of DP thymocytes and increased proportion of DN 
thymocytes in CXCR4/ mice (Fig. 8 A). We also observed 
Figure 6.  PI3K p110 and p110 are required for CXCR4 signaling in DN3 thymocytes. (A) Phosphorylated Akt (S473) or (B) phosphorylated 
Erk1/2 (T202/Y204) in WT and PI3K mutant DN3 thymocytes after stimulation with CXCL12. Histograms show staining of resting cells or cells stimulated 
with 10 nM of CXCL12 for either 1 min (p-Akt) or 2 min (p-Erk1/2). Single-cell suspensions of whole thymus were used for stimulation. Intracellular p-Akt 
(S473) and p-Erk1/2 was detected using flow cytometry in combination with cell surface markers to distinguish the DN3 population. (C) Time course of  
p-Akt (S473) induction in WT DN3, DN4, DP, and CD4+SP thymocytes. (D) Time course of p-Akt (S473) induction in WT, p110/, p110/, p101/, and 
p110// DN3 thymocytes. Data are presented as fold induction, which is calculated as the median fluorescence of phosphorylated protein in  
stimulated/unstimulated cells. Each data point shows the mean and SD of three to four biological replicates and is comprised from two independent 
experiments.JEM VOL. 207, January 18, 2010 
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regulation occurred, the cells increased in size and DP cells 
were formed (Fig. 9, A–C). The effect of CXCL12 was 
found to be dose-dependent (Fig. S3, B-C). The absolute   
requirement for preTCR signaling in this culture system was 
also confirmed as Rag2/ DN3 cells failed to differentiate 
(unpublished data). The effect of CXCL12 could not be sub-
stituted by two other chemokines. Culturing DN3 cells in 
the presence of a CCR5 ligand CCL5 did not induce DP 
differentiation (Fig. 9 A), nor did it have any additive effects 
in combination with CXCL12 (not depicted). Similarly,   
the addition of CCL25 neither reproduced nor potentiated 
the effect of CXCL12 (Fig. 9 A). Together, these results   
CXCL12, together with Notch ligand, allows  
for the differentiation of DN3 cells in vitro  
without supporting stroma
Our findings suggest that, in addition to the preTCR and 
Notch, DN3 cells also require signals through CXCR4 for 
their continued development. When sorted DN3 cells were 
cultured  with  the  recombinant  Notch  ligand  Delta-like   
4 (rDL4), they failed to proliferate or differentiate and mini-
mally increased expression of CD98, demonstrating the   
requirement for a factor(s) in addition to the preTCR and 
Notch (Fig. 9, A–C). In contrast, when DN3 cells were   
cultured in the presence of rDL4 with CXCL12, CD98 up-
Figure 7.  PI3K activity increases during -selection. (A) CD98lo (red) and CD98hi (blue) DN3 thymocytes were sort purified from WT mice before 
fixation, permeabilization, and intracellular staining for p-Akt (S473). The fold change in p-Akt was calculated as the median fluorescence of p-Akt in 
CD98hi compared with CD98lo cells. (B and C) 4 × 104 DN3 cells from WT mice were cultured on OP9-DL1 stromal cells for 3 d in the presence of increas-
ing concentrations of AMD3100. At 24 (red), 48 (blue), and 72 h (green) cells were harvested and analyzed for the expression of p-Akt. The fold change  
in p-Akt levels was measured relative to cells harvested at 24 h that had been cultured in the absence of AMD3100. Results presented in A–C are from a 
single experiment of three biological replicates (with each biological sample comprising a pool of sorted cells from five mice). (D) p-Akt (S473) expression 
in DN3 cells isolated ex vivo from PI3K mutant mice. Data are presented as p-Akt expression relative to WT and 4–11 mice were analyzed for each  
genotype. All graphs show the mean and SD.256 PI3K signals through CXCR4 at -selection | Janas et al.
on OP9-DL1. This result suggests a role for the GSK3 sig-
naling pathway in DN3 cells and further demonstrates that 
CXCL12 is required for optimal differentiation and prolifera-
tion. In contrast to WT DN3 cells, p110/// DN3 
cells  failed  to  differentiate  when  cultured  with  rDL4  and 
CHIR99021.  Further,  the  addition  of  CXCL12  did  not   
enhance the numbers of p110/// cells recovered or 
support their differentiation. Thus, for DN3 cells cultured 
under in vitro conditions, p110 and p110 activation is   
absolutely required for CXCR4-dependent expansion and 
differentiation.
DISCUSSION
Until recently, T cell development in vitro was studied in the 
context of fetal thymic organ cultures. The creation of the 
OP9-DL1  stromal  cell  line  allowed  the  differentiation  of 
HSCs into functional T cells in a two-dimensional culture 
system (Schmitt and Zuñiga-Pflucker, 2002). Exploitation of 
this system has allowed T cell precursors to be genetically 
manipulated and subsequently used in the treatment of tumor 
models in mice (Zakrzewski et al., 2008). Accessory cell–free 
culture conditions for T cell precursors have been described 
previously, but these did not permit cells to differentiate   
demonstrate that signaling through the preTCR, Notch, and 
CXCR4 combine to promote in vitro thymocyte differen-
tiation beyond the DN3 stage.
Inhibition of GSK3 augments in vitro  
thymocyte development
The combination of rDL4 and CXCL12 defined minimal re-
quirements for a stromal cell–free in vitro system that pro-
moted thymocyte differentiation. However, these conditions 
did not support DN3 cell proliferation or differentiation to 
the same extent as the OP9-DL1 stromal cell line, suggesting 
that additional factors were contributed by the OP9-DL1 
cells. Glycogen synthase kinase 3 (GSK3) has been impli-
cated as a regulator of multiple signaling pathways, and we 
tested whether inhibition of GSK3 in DN3 cells could fur-
ther augment the stromal-free in vitro culture. DN3 cells 
from WT and p110/// mice were cultured on rDL4 
with the GSK3 inhibitor CHIR99021 in the presence or 
absence of CXCL12 (Fig. 9, D and E). CHIR99021 enabled 
the  differentiation  of  WT  DN3  cells  in  the  absence  of 
CXCL12, but together CHIR99021 and CXCL12 increased 
the proportion of cells that became CD4+CD8+ and increased 
cell numbers to that achieved when DN3 cells were cultured 
Figure 8.  Embryonic thymic development is perturbed in CXCR4-deficient mice. Thymocyte composition fin E17.5 CXCR4+/ or CXCR4/  
embryos (A, top). Flow cytometric analysis of CD4 and CD8 expression. The percentages of CD4+CD8+ (DP) and CD4CD8 (DN) cells are shown. (A, bottom) 
Flow cytometric analysis CD25 and CD44 expression on CD3/CD4/CD8neg thymocytes. The percentages of CD44hiCD25lo (DN1), CD44hiCD25hi (DN2),  
CD44loCD25hi (DN3), and CD44l°CD25lo (DN4) are shown. (B and C) The number of DN1, DN2, DN3, DN4, and DP thymocytes. For subset analysis, the ratio  
of CXCR4/ to CXCR4+/ numbers is shown. (D) Comparison of CXCR4+/ and CXCR4/ DN3 and DN4 cell size based on forward light scatter analysis.  
Size is represented relative to CXCR4+/. All graphs represent the mean and SD (n = 3).JEM VOL. 207, January 18, 2010 
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The combination of rDL4 and CXCL12 alone did not 
support DN3 cell proliferation or differentiation to the same 
extent as the OP9-DL1 stromal cell line. This might have 
been caused by the suboptimal presentation of the Notch   
ligand, which varies in effectiveness depending on density 
(Dallas et al., 2005). Similarly, presentation of CXCL12, 
which binds to extracellular matrix (Amara et al., 1999), may 
not be optimal in our system. It is likely that an additional 
factor besides Notch, preTCR, and CXCL12 are required 
for the proliferation and differentiation of DN3 cells. Utiliza-
tion of the GSK3 inhibitor CHIR99021, in conjunction 
with CXCL12, appeared to compensate for this and allowed 
the proliferation and differentiation of DN3 cells to a similar 
degree to that observed when cultured with OP9-DL1. 
CHIR99021  did  not  potentiate  the  differentiation  of 
p110// DN3 cells; however, indicating that it was not 
able to compensate for the lack of PI3K. It is possible that the 
beyond the DN2 stage (Dallas et al., 2007). This suggests that 
additional factors elaborated by the stromal cell line contrib-
ute to the proliferation and differentiation of thymocytes. 
However, the identity of these additional factors has remained 
unknown. Here, we have provided evidence that CXCR4 
and its ligand CXCL12, which is produced by OP9-DL1, are 
important for the proliferation and differentiation of DN3 
cells.  CXCR4  was  identified  as  being  essential  in  the   
OP9-DL1 culture system through the use of highly selective 
receptor antagonists. CXCL12 promoted DN3 differentia-
tion that was dependent on Notch and the preTCR. We 
suggest these three receptors are functionally nonredundant, 
with each receptor–system interacting to promote continued 
thymic development beyond -selection. Our findings offer 
the possibility of studying thymocyte development in a stro-
mal cell–free system in which the effects of extrinsic factors 
or genetic manipulation can be controlled.
Figure 9.  Establishment of an accessory cell–free culture system for the differentiation of immature thymocytes. (A–C) 105 DN3 cells from  
WT mice were cultured on OP9-DL1 or OP9 stromal cells, plate-bound recombinant Delta-like 4 (rDL4), CXCL12, or rDL4 and either CXCL12, CCL5, or 
CCL25. After 3 d, cells were harvested and analyzed for the percentage of CD4+CD8+, CD4CD8 (A) cells and the percentage of CD98+ cells (B). (C) The 
total number of cells harvested under different culture conditions. The graph shows the mean and SEM of five biological replicates, except for cells  
cultured with CXCL12 alone, where n = 1. (D and E) 105 DN3 cells from WT or p110// mice were cultured with rDL4 with 10 µM CHIR99021 in the 
presence or absence of 10nM CXCL12. After 3 d, cells were harvested and analyzed for the percentages of CD4+CD8+ and CD4CD8 cells (D) and the 
total number of cells harvested (E). The graph shows the mean and SD of two biological replicates. Results from WT represent one of three experiments.258 PI3K signals through CXCR4 at -selection | Janas et al.
concentrated at the subcapsular zone (Plotkin et al., 2003), 
which is where the most intensive proliferation of thymo-
cytes is known to occur.
Although p110 appears to be relatively more impor-
tant  for  Akt  phosphorylation  after  CXCR4  activation   
in DN3 cells, p110 clearly plays an ancillary role as the   
p-Akt response of the p110// or p101//p110/ 
double mutants was further reduced when compared with 
the p110/ or p101/ single mutants. The potential of 
class IA PI3K to contribute to CXCR4 signaling has been 
noted  previously  in  studies  using  Jurkat  cells  (Curnock   
et al., 2003). In peripheral T cells, CXCR4 signaling leads 
to the phosphorylation of Lck and Zap-70 (Patrussi et al., 
2007),  possibly  via  direct  interactions  with  the  TCR   
(Kumar et al., 2006; Contento et al., 2008). It is not yet 
known whether these mechanisms are relevant to p110-
mediated CXCR4 signaling in DN thymocytes; however, 
we have noted that pAkt responses to CXCL12 are intact in 
DN3  cells  from  Rag-2  mutant  mice  (unpublished  data). 
Thus, TCR is dispensable for PI3K-mediated CXCR4 
signaling in DN3 cells.
CXCL12 is predominantly considered as a chemokine 
but it has been recently shown to enhance the proliferation 
and activation of CD3-stimulated peripheral T cells (Molon 
et  al.,  2005).  Indeed  CXCL12  was  originally  identified 
through its preB cell growth factor properties (Nagasawa   
et  al.,  1994).  Our  results  with  stromal  cell–free  in  vitro   
cultures suggest that CXCL12 also promotes the growth 
and differentiation of developing thymocytes. Presumably, 
in stromal cell–free culture, this function of CXCL12 is in-
dependent  of  any  chemotactic  activity.  Notch  has  been 
documented as a regulator of DN3 metabolism (Ciofani   
and  Zuñiga-Pflucker,  2005)  but  our  results  demonstrate 
that the provision of a Notch signal alone to DN3 thymo-
cytes is not sufficient to support the metabolic changes asso-
ciated with -selection and that CXCL12 was additionally 
required. The contribution of CXCL12 to DN3 cell sur-
vival, proliferation, and differentiation have yet to be fully 
addressed, but further investigation using specific CXCR4 
inhibitors  in  combination  with  mathematical  modeling   
of time course data may provide further insight (Callard   
and Hodgkin, 2007).
Our findings may be relevant in the context of some T   
cell acute lymphoblastic leukemias (T-ALLs) as altered Notch 
and  PI3K  signaling  frequently  underpins  the  transformed   
phenotype of these cells, yet primary explants of these tumors 
are  prone  to  apoptosis  and  difficult  to  propagate  in  vitro   
(Armstrong et al., 2009). Recently, some primary T-ALLs 
were propagated on stromal cell lines expressing recombinant 
Notch  ligand  (Armstrong  et  al.,  2009).  Our  finding  that 
CXCL12 promotes growth in concert with Notch and the 
preTCR may be relevant to the in vitro culture of T-ALL and 
prompts the hypothesis that CXCL12 may have an in vivo role 
in T-ALL. Examining the responses of T-ALL to AMD3100 
alone or in combination with other drugs with efficacy against 
T-ALL may suggest a new therapeutic modality.
GSK3  inhibitor  may  promote  Wnt/-catenin  signaling   
that has been identified as important for T cell development 
at the -selection checkpoint (Gounari et al., 2001; Xu et al., 
2003).  Alternatively,  CHIR99021  may  be  potentiating   
the effects of Notch (McKenzie et al., 2006) or regulating 
Hedgehog signaling, which has also been shown to regulate 
DN thymocyte differentiation (Outram et al., 2000). These 
issues can be explored further using an accessory cell–free 
culture system.
Although we have shown here that T cell development   
is impaired in CXCR4 knockout mice, controversy exists   
regarding the role of CXCR4 in T cell development (Ma   
et al., 1998; Zou et al., 1998; Kawabata et al., 1999; Ara   
et al., 2003; Plotkin et al., 2003). These discrepancies may   
be caused by the differing requirements for T lymphopoiesis 
in the fetal and adult thymus. For example, fetal T cell de-
velopment has been shown to be independent of the IL-7   
receptor (Crompton et al., 1998) and 4 integrin (Arroyo   
et al., 1996), but these molecules are essential for postnatal   
T cell development. However, a complete block in adult   
T cell development upon the conditional deletion of CXCR4 
in DN1 cells in chimeric mice suggests that CXCR4 is im-
portant for directing T cell progenitors beyond the cortico-
medullary junction in the adult thymus (Plotkin et al., 2003). 
To fully explore the role for CXCR4 at the later develop-
mental stage of -selection in the adult, a conditional model 
whereby CXCR4 is deleted upon the expression of TCR 
is required.
The identification of a critical role for CXCR4 signaling 
arose from an investigation into the functional redundancy 
between PI3K isoforms during T cell development. This 
study has identified receptors through which each of these 
catalytic isoforms is activated. PreTCR-mediated PI3K acti-
vation is p110 dependent. In contrast, activation of PI3K   
by CXCR4 is predominantly mediated by p110 in a p101-
dependent  manner.  Activation  of  PI3K  signaling  through 
CXCR4 at the point of -selection is critical, as in the pres-
ence of CXCR4 antagonists the phosphorylation of the PI3K 
effector Akt in DN3 cells is impaired and cells fail to differ-
entiate. The relatively normal phenotypes of the p110/, 
p110/, and p101/ DN thymocytes suggest that the loss 
of one catalytic isoform is compensated for by the presence of 
the other and that major defects in thymocyte development 
are only observed when class IA and IB PI3K subunits are   
inactivated simultaneously. Thus, p110/ DN3 cells are 
unable to phosphorylate Akt downstream of the preTCR, 
but possess a robust p-Akt response to CXCR4 stimulation 
caused by the presence of p110. Conversely, the ability of 
p110/  and  p101/  thymocytes  to  phosphorylate  Akt 
upon CXCR4 stimulation is poor, but their PI3K response 
to preTCR signaling, mediated by p110, is intact. In each of 
these scenarios, PI3K activity in DN3 cells is sufficient for 
continued thymocyte development. The mechanistic ratio-
nale for having multiple cell surface receptors activate the 
same growth promoting pathway may be to promote prolif-
eration in defined regions of the thymus. Thus, CXCL12 is JEM VOL. 207, January 18, 2010 
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resuspension at 107 cells/ml in supplemented -MEM. Cells were incu-
bated at 37°C for 20 min before the addition of 10 µg/ml of the -CD3 
monoclonal antibody 2C11. At various time intervals, 106 cells were fixed 
in 2% paraformaldehyde, washed in PBS, and resuspended in 90% ice-cold 
methanol at 20°C for at least 30 min. Cells were then washed three times 
in PBS with 2% FCS before incubation with antibodies to surface markers 
as well as to phosphorylated Akt (clone #4058; Cell Signaling Technology) 
or phosphorylated-Erk (clone #4370; Cell Signaling Technology) for   
30 min at room temperature. Phosphospecific antibodies were detected by 
subsequent incubation with Cy5-conjugated donkey anti–rabbit antibody. 
Cells were then analyzed by FACS. CXCL12 stimulation studies were con-
ducted as above, except that unfractionated thymocyte suspensions were 
resuspended at 107 cells/ml in DMEM with 0.1% BSA. Cells were incu-
bated at 37°C for 20 min before the addition of 10 nM CXCL12. For data 
analysis, fold induction was calculated as the median fluorescence of stimu-
lated sample/median fluorescence of unstimulated sample. Unstimulated 
samples showed no increase in phospho-Akt or phospho-Erk throughout 
the timecourse.
RT-PCR  analysis.  RNA  was  extracted  from  106  isolated  cells  using 
TRIzol (Invitrogen) and converted to cDNA. Controls without reverse 
transcription were included for all samples. p101 and p84 mRNA was   
quantified using a Taqman probe and normalized to the expression of   
2 microglobulin (Applied Biosystems).
Western blots. Lysates from 106 thymocytes were separated by SDS-PAGE 
and transferred to nitrocellulose. Blots were probed with rabbit anti-p110 
(Onxy Pharmaceuticals) and antibody binding was revealed using HRP-
conjugated anti–rabbit antibody (Dako) followed by ECL (GE Healthcare). 
Blots were subsequently probed using mouse anti- actin.
Statistics. Data presented throughout represent the mean and either the SD 
or SEM (if n ≥ 5). For statistical analyses containing two groups, data were 
analyzed using unpaired Student’s t test and P values are shown in the   
figures. For statistical analyses containing more than two groups, data were 
analyzed by one-way analysis of variance and statistical significance repre-
sented as: *, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with WT, 
except for the data in Fig. 4 where statistical significance is shown compared 
with cells cultured without agonist.
Online supplemental material. Fig. S1 presents the FACS profile of DN3 
and DN4 cells derived from long-term BM HSC cultures. Fig. S2 pres-
ents relative RNA expression levels of the PI3K isoforms p101 and p84 in 
WT DN3 and DN4 cells, as well as p110 protein levels in WT, p101/ 
and p110/ thymus lysates. Fig. S3 presents the secretion of CXCL12 
by OP9-DL1 stromal cells as well as the cellular responses of WT DN3 
cells  cultured  in  the  presence  of  increasing  concentrations  of  CXCL12. 
Online  supplemental  material  is  available  at  http://www.jem.org/cgi/ 
content/full/jem.20091430/DC1.
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MATERIALS AND METHODS
Mice. Mice with deletions of p110, 110, p101, and CXCR4 have been 
described previously (Tachibana et al., 1998; Webb et al., 2005; Suire et al., 
2006). Mice were on 129/B6 mixed backgrounds and 5–13 wk of age,   
except CXCR4-deficient mice which were on a B6 background and ana-
lyzed at embryonic day 17.5. For chimera studies, irradiated Rag2/Il2r/ 
mice  were  injected  intravenously  with  3  ×  106  BM  cells  from  WT, 
p110//, or p101//p110/ mice and analyzed 8–12 wk later. All 
mice husbandry and experimentation were in accordance with UK Home 
Office regulations and local ethical review (except CXCR4 embryo studies, 
which were approved by the animal ethics committee of the Institute for 
Frontier Medical Sciences, Kyoto University).
Cell isolation. BM-derived HSCs were isolated from single-cell suspen-
sions of BM by a two-step process using lineage depletion followed by ScaI+ 
enrichment by MACS (Miltenyi Biotec). Typically, the ScaI+-enriched pop-
ulation represented 0.1% of the starting BM preparation. DN3 and DN4 
thymocytes were isolated by FACS. Single-cell thymocyte suspensions were 
first enriched for DN cells by incubation with biotinylated anti-CD8 anti-
body followed by streptavidin-coated MACS beads and magnetic depletion 
before staining for DN subsets. DN3 and DN4 cells were isolated as Thy1+, 
[CD4/CD8/CD44/B220/CD11b/NK1.1/Gr1/Ter119/TCR]neg and 
either CD25hiCD98lo (DN3) or CD25loCD98hi (DN4).
Cell  culture.  OP9  and  OP9-DL1  cells  were  maintained  as  previously   
described (Ciofani and Zuñiga-Pflucker, 2005). BM-derived HSCs were 
cultured in -MEM supplemented with 20% FCS, 100 U/ml penicillin,   
100 µg/ml streptomycin, 5 × 105M 2ME, 10 ng/ml recombinant IL-7, and 
5 ng/ml recombinant Flt3L (PeproTech) at a density of 4 × 103 cells/ml in 
24-well tissue culture plates that had been seeded with 2 × 104 OP9-DL1 
cells. After 7 d, and at weekly intervals thereafter, cells were harvested, passed 
through a 40-µM filter, and recultured at 2 × 105 cells/ml in 24-well tissue 
culture plates that had been seeded with 2 × 104 OP9-DL1 cells in supple-
mented -MEM complete with IL-7 and Flt3L. For assays using sorted DN3 
thymocytes on OP9-DL1 cell lines, 4 × 104 cells were cultured in supple-
mented -MEM, without additional cytokines, in 96-well plates that had 
been  previously  seeded  with  4,000  OP9-DL1  cells.  AMD3100  (Sigma-
  Aldrich) and GSK812397A (GlaxoSmithKline) were added with the DN3 
cells at the start of culture. For stromal cell–free cultures, 105 DN3 cells were 
cultures in 96-well plates that had been coated overnight with 10 µg/ml of 
recombinant mouse Delta-like ligand 4 (R&D Systems) supplemented with 
-MEM in the presence or absence of recombinant CXCL12 (10 nM), 
CCL5 (10 nM), CCL25 (10 ng/ml; PeproTech), and/or CHIR99021 (10 µM; 
Axon MedChem). For controls, equivalent cell numbers were cultured 
on OP9 or OP9-DL1 stromal cells. Assays using sorted DN3 cells were   
harvested after 3 d of culture and analyzed by FACS. Cell numbers were 
determined by reference to the inclusion of a fixed number of micro-
beads (Spherotech).
Thymocyte population analysis by FACS. Single cell suspensions from 
the thymus or cultured cells were stained using various combinations of an-
tibodies conjugated to fluorochromes for analysis by FACS (LSRII; BD). 
DN3/DN4 thymocytes were identified as Thy1+ and [CD4/CD8/CD44/
B220/CD11b/NK1.1/Gr1/Ter119/TCR]neg. For intracellular staining, 
cells were treated with BD Cytofix/Cytoperm solutions before staining for 
cell-surface markers in conjunction with PE-conjugated anti-mouse TCR 
(clone H57) or intracellular Notch1 (clone mN1A; BD).
EdU incorporation studies. Mice were injected intraperitoneally with 
100 µg of EdU in PBS. After 4 h, thymi were harvested and single-cell sus-
pensions were prepared and stained for cell surface markers. Cells were then 
prepared for EdU detection as per the manufacturer’s instructions (Invitro-
gen; Salic and Mitchison, 2008).
Phosphospecific flow cytometry. For preTCR stimulation studies, cul-
tured cells were harvested, washed, and passed through a 40-µM filter before 260 PI3K signals through CXCR4 at -selection | Janas et al.
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